Candida species are the most common fungal pathogens isolated from the oral cavity. Their oral existence both as a commensal and an opportunist pathogen has intrigued clinicians and scientists for many decades, and recent investigations have revealed many attributes of this fungus contributing to its pathogenicity. In addition, the advent of the human immunodeficiency virus infection and AIDS has resulted in a resurgence of oral Candida infections. Clinicians are witnessing not only classic forms of the diseases but also newer clinical variants such as erythematous candidosis, rarely described hithertofore. Therefore, this review is an attempt at detailing the current knowledge on Candida and oral candidoses together with the newer therapeutic regimes employed in treating these mycoses.
References
1.
Allen, C.M. and F.M. Beck: Strain-Related differences in pathogenicity of Candida albicans for Oral Mucosa. J. Infect. Dis. 147:1036-1040 (1983 ).
2.
Amman, A.J.: Selective IgA Deficiency: Presentation of 30 Cases and a Review of the Literature. Medicine50:223-236 (1971).
3.
Antley, P.P. and K.C. Hazen: Role of Yeast Cell Growth Temperature on Candida albicans Virulence in Mice. Infect. Immun. 56:2884-2890 (1988 ).
4.
Arendorf, T.M., D.M. Walker, R.J. Kingdom, R.J. Roll, and R.G. Newcombe: Tobacco Smoking and Denture Wearing in Oral Candidal Leukoplakia. Br. Dent. J. 155:340-343 (1983).
5.
Arendorf, T.M. and D.M. Walker: Oral Candidal Population in Health and Disease. Br. Dent. J. 147:267-272 (1979).
6.
Arendorf, T.M. and D.M. Walker: The Prevalence and Intra-Oral Distribution of Candida albicans in Man. Arch. Oral Biol. 25:1-10 (1980).
7.
Armstrong, D., J.W.M. Gould, J. Dryjanski, E. Whimby, B. Polsky, C. Hawkins, A. Brown, E. Bernard, and T.E. Riehn: Treatment of Infections in Patients with the Acquired Immune Deficiency Syndrome. Ann. Intern. Med. 103:738-743 (1985).
8.
Ashman, R.B. and J.M. Papadimitriou: What's New in the Mechanisms of Host Resistance to Candida albicans Infection? Path. Res. Pract. 186:527-534 (1990).
9.
Ayliffe, G.: Trends in Resistance and Their Significance in Primary Pathogenic Bacteria. In: Recent Advances in Infection. pp. 123-129. ( D. Reeves and A. Gedds, Eds.) Churchill Livingstone, Edinburgh (1979).
10.
Banoczy, J.: Follow-Up Studies in Oral Leukoplakia. J. Maxillofac. Surg. 5:69-75 (1977).
11.
Barlow, A.J.E. and F.W. Chattaway: Observations on the Carriers of Candida albicans in Man. Br. J. Dermatol. 81:103-106 (1969).
12.
Bastiaan, R.J. and P.C. Reade: The Prevalence of Candida albicans in the Mouths of Tobacco Smokers with and without Oral Mucous Membrane Keratosis. Oral Surg. Oral Med. Oral Pathol. 53:148-151 (1982).
13.
Bird, G.W. and G.H. Tovey: The Blood Groups. In: Blood and Its Disorders. pp. 1339-1431. (R. M. Hardisty and D. J. Weatherall, Eds.) Blackwell Scientific, Oxford (1982).
14.
Blackwell, C.C., S.M. Thorn, D.M. Weir, D.F. Kinane, and F.D. Johnstone: Host-Parasite Interactions Underlying Non-Secretion of Blood Group Antigens and Susceptibility to Infections by Candida albicans. In: Protein-Carbohydrate Interactions in Biological Systems. pp. 231-233. (D. L. Lark, Ed.) Academic Press, London (1986).
15.
Blank, F., O. Chin, G. Just, Dr. Meranze, M.B. Shimkin, and R. Wieder: Carcinogens from Fungi Pathogenic for Man. Cancer Res. 28:2276-2281 (1968).
16.
Blatchford, N.R.: Treatment of Oral Candidosis with Itraconazole: A Review. J. Am. Acad. Dermatol. 23:565-567 (1990).
17.
Bodey, G., G. Samonis, and K. Rolston: Prophylaxis of Candidiasis in Cancer Patients. Semin. Oncol. 17(Suppl. 6): 24-28 (1990).
18.
Bodey, G.P., and E.J. Anaissie: Chronic Systemic Candidiasis. Eur. J. Clin. Microbiol. Infect. Dis. 8:855-857 (1989).
Borg, M. and R. Ruchel: Expression of Extracellular Acid Proteinase by Proteolytic Candida spp. during Experimental Infection of Oral Mucosa. Infect. Immun. 56:626-631 (1988).
21.
Braathen, L.R., G. Ramirez, R. Kunze, et al.: Langerhans Cells as Primary Target Cells for HIV Infection. Lancetii: 1094 (1987).
22.
Brammer, K.W., P.R. Farrow, and J.W. Faulkner: Pharmacokinetics and Tissue Penetration of Fluconazole in Human. Rev. Infect. Dis. 12:318-326 (1990).
23.
Brass, C., J. Galgiani, T. Blaschke, et al.: Disposition of Ketoconazole, an Oral Antifungal in humans. Antimicrob. Agents, Chemoth. 21(1):151-158 (1982).
24.
Breckenridge, A.: Clinical Significance of Interactions with Antifungal Agents. Br. J. Dermatol. 126(Suppl. 39): 19-22 (1992).
25.
Brown, L.R., S. Dreizen, S. Handlers, and D.A. Johnston: The Effect of Radiation-Induced Xerostomia on Saliva and Serum Lysozyme and Immunoglobulin Levels. J. Dent. Res. 54:740-750 (1975).
26.
Budtz-Jorgensen, E.: Candida-Associated Denture Stomatitis and Angular Cheilitis. In: Oral Candidosis, Chap. 9. (L. P. Samaranayake and T. W. MacFarlane, Eds.) Butterworth, London (1990).
27.
Budtz-Jorgensen, E.: The Significance of Candida albicans in Denture Stomatitis. Scand. J. Dent. Res. 82:151-203 (1974).
28.
Burford-Mason, A., R. Matthews, and Y. Williams: Transient Abrogation of Immunosuppression in a Patient with Chronic Mucocutaneous Candidosis Following Vaccination with C. albicans. J. Infect. 14:147-157 (1987).
29.
Burket, L.W.: Oral Medicine in the Edentulous Patient. In: Burket's Oral Medicine: Diagnosis and Treatment, 7th ed., pp. 568-581. (Lynch, M. A., Ed.) J.B. Lippincott Co., Philadelphia (1977 ).
30.
Burnie, J., R. Matthews, J. Watson, D. Milligan, and S. Tabaqchali: Analysis of the Antibody Response Developing in an Infant with C. albicans Meningitis. J. Infect. 12:79-83 (1986).
31.
Burnie, J. and R. Matthews: Heat Shock Protein 88 and Aspergillus infection. J. Clin. Microbiol. 29:2099-2106 (1991).
32.
Carpentier, M.F., T.E. Kiehn, and D. Armstrong: Fungemia in the Immunocompromised Host. Am. J. Med. 71:363-370(1981).
33.
Cawson, R. and T. Lehner: Chronic Hyperplastic Candidiasis-Candidal Leukoplakia. Br. J. Dermatol. 30:9-16 (1968).
34.
Cawson, R.A. and W.H. Binnie: Candida Leukoplakia and Carcinoma: A Possible Relationship. In: Oral Premalignancy. Proceedings of the First Dows Symposium, pp. 59-66. (I. C. MacKenzie, E. Dabelsteen, and C. A. Squier, Eds.) University of Iowa Press, Iowa City ( 1980).
35.
Cawson, R.A.: Chronic Oral Candidosis, Denture Stomatitis and Chronic Hyperplastic Candidosis. In: Symposium on Candida infections, pp. 139-152. (H. I. Winner and R. Hurley, Eds.) E & S Livingstone, Ltd. Edinburgh ( 1966).
36.
Cawson, R.A.: Thrush in Adult Out-Patients. Dent. Prac. 15:361-365 (1965).
37.
Centres for Disease Control: Revision of the Case Definition of Acquired Immune Deficiency Syndrome for National Reporting. United States. MMWR34:373-375 (1985).
38.
Cemea, P., C. Crepy, R. Kuffer, J.M. Mascaro, G. Badillet, and J.L. Marie: Aspects peu connus de candidoses buccales. Les Candidases a Foyers Multiples de la Cavite Buccale. Revue de Stomatologie (Paris)66:103-138 (1965).
39.
Chemosky, M.E.: Relationship between Vertical Facial Dimension and Perleche. Arch. Dermatol. 93:332-337 (1966).
40.
Conly, J., R. Renine, J. Johnson, S. Farah, and L. Hellman: Disseminated Candidosis Due To Amphotericin B-Resistant Candida albicans. J. Infect. Dis. 165:761-764 (1992).
41.
Critchley, I.A. and L.J. Douglas: Isolation and Partial Characterisation of an Adhesion from Candida albicans. J. Gen. Microbiol. 133:629-636 (1987).
42.
Cumming, C.L., C. White, C.L. Blackwell, and D. Wray: Denture Stomatitis in the Elderly. Oral Microbiol. Immunol. 5:82-85 (1990).
43.
Cutler, J.E., L. Friedman, and K.C. Milner: Biological and Chemical Characterisation of Toxic Substances from Candida albicans. Infect. Immun. 6:616-627 (1972).
44.
Daftary, D.K., F.S. Mehta, P.C. Gupta, and J.J. Pindborg: The Presence of Candida in 723 Oral Leukoplakias among Indian Villagers. Scand. J. Dent. Res. 80:75-79 (1972).
45.
Daniels, T.E., O. Schwartz, V. Larsen, E. Dabelsteen, and J.J. Pindborg: Langerhans Cells in Candidal Leukoplakia. J. Oral Pathol. 14:733-739 (1985).
46.
Darwazeh, A.M., P.J. Lamey, M.A. Lewis, and L.P. Samaranayake: Systemic Fluconazole Therapy and In Vitro Adhesion of Candida albicans to Human Buccal Epithelial Cells. J. Oral Pathol. Med. 20:17-19 (1991).
47.
Darwazeh, A.M., P.J. Lamey, L.P. Samaranayake, T.W. MacFarlane, B.M. Fisher, S.M. MacRury, and A.C. MacCuish: The Relationship between Colonisation, Secretor Status and In Vitro Adhesion of Candida albicans to Buccal Epithelial Cells from Diabetics. J. Med. Microbiol. 33:43-49 (1990).
48.
Davenport, J.C.: The Oral Distribution of Candida in Denture Stomatitis. Br. Dent. J. 129:151-156 (1970).
49.
deWit, S., H. Goossens, D. Weert, and N. Clumeck: Comparison of fluconazole and Ketoconazole for Oropharyngeal Candidiasis in AIDS. Lanceti:746-747 (1989).
50.
Diamond, R.D.: Fungal Surfaces: Effects of Interactions with Phagocytic Cells. Rev. Inf. Dis. 10:5428-5431 (1988).
51.
Djeu, J.Y., D.R. Blanchard, D. Halkias, and H. Friedman: Growth Inhibition of Candida albicans by Human Polymorphonuclear Neutrophils: Activation by Interferon-Gamma and tumor Necrosis Factor. J. Immunol. 137:2980-2984 (1986).
52.
Dobias, B.: Specific and Nonspecific Immunity in Candida Infections. Acta Med. Scand. 176(Suppl. 421):1-79 (1964).
53.
Dodd, C.L., D. Greenspan, M.H. Katz, J.L. Westenhouse, J.W. Feigal, and J.S. Greenspan: Oral Candidiasis in HIV Infection: Pseudomembraneous and Erythematous Candidiasis Show Similar Rates of Progression to AIDS. AIDS5:1339-1343 (1991).
54.
Dorey, J. and B. Blasberg: Oral Mucosal Disorders in Denture Wearers. J. Prosthet. Dent. 53:210-214 (1985).
55.
Dreizen, S., K.B. McCredie, M.J. Keating, and G.P. Bodey: Oral Infections associated with Chemotherapy in Adults with Acute Leukemia. Postgrad. Med. 71:133-146 (1982).
56.
Drouhet, E. and B. Dupont: Candidosis in Heroin Addicts and AIDS: New Immunologic Data on Chronic Mucocutaneous Candidosis. In: Candida and Candidamycosis (E. Tumbay, Ed.) Plenum Press, New York (1991).
57.
Drug and Therapeutics Bulletin: Management of Oral Candidosis 28:12-15 (1990).
Epstein, J.B., L.H. Kimura, T.W. Menard, E.L. Truelove, and N.N. Pearsall: Effects of Specific Antibodies on the Interaction Between the Fungus Candida albicans and Human Oral Mucosa. Arch. Oral Biol. 27:469-474 (1982).
60.
Epstein, J.B., N.N. Pearsall, and E.L. Truelove: Quantitative Relationships between the Candida albicans in Saliva and the Clinical Status of Human Subjects. J. Clin. Microbiol. 12:475-476 (1980).
61.
Epstein. J.B., E.L. Truelove, and K.T. Izutzu: Oral Candidiasis: Pathogenesis and Host Defence. Rev. Infect. Dis. 6:96-106 (1984).
62.
Escobar, V., A.G. Farman, and R.N. Arm: Oral Gonococcal Infection. Int. J. Oral Surg. 13:549-554 (1984).
63.
Esterly, N.B., S.R. Brommer, and R.G. Crounse: The Relationship of Transferrin and Iron to Serum Inhibition of Candida albicans. J. Invest. Dermatol. 49:437-442 (1967).
64.
Evans, T.G., J. Mayer, S. Cohen, D. Classen, and K. Carroll: Fluconazole Failure in the Treatment of Invasive Mycoses. J. Infect. Dis. 164:1232-1235 (1991).
65.
Farrow, P.: Levels of Fluconazole in Sputum. Memorandum, Pfizer Central Research, Sandwich, England (1987 ).
66.
Field, S.A., J.K. Field, and M.V. Martin: Does Candida Have a Role in Oral Epithelial Neoplasia? J. Med. Vet. Mycol. 27:277-294 (1989).
67.
Finlay, I.G.: Oral Symptoms and Candida in the Terminally III. Br. Med. J. 292:592-593 (1986).
68.
Fisker, A.V., C. Rindom-Schiott, and H.P. Philipsen: Long-Term Oral Candidosis in Rats. Acta Pathol. Microbiol. Immunol. Scand. Sect. B90:221-227 (1982).
69.
Fox, B.C., H.L.T. Mobley, and J.C. Wade: The Use of a DNA Probe for Epidemiological Studies of Candidiasis in Immunocompromised Hosts. J. Infect. Dis. 159:488-494 (1989).
70.
Franklin, C.D. and M.V. Martin: The Effects of Candida albicans on Turpentine-Induced Hyperplasia of Hamster Cheek Pouch Epithelium. J. Med. Vet. Mycol. 24:281-287 (1986).
71.
Franklin, I., E. Elias, and C. Hirsch: Fluconazole-Induced Jaundice. Lancet19:565 (1990).
72.
Galgiani, J.: Fluconazole: A New Antifungal Agent. Annal. Intern. Med. 113:177-179 (1990).
73.
Grappel, S.F. and R.A. Calderone: Effect of Antibodies on the Respiration and Microbioloby of Candida albicans. Sabouraudia14:51-60 (1976).
74.
Graybill, J.R.: Future Direction of Antifungal Chemotherapy. Clin. Infect. Dis. 14:S170-S181 (1992).
75.
Graybill, J.R.: New Antifungal Agents. Eur. J. Clin. Microbiol. Infect. Dis. 8:402-412 (1989).
76.
Greenfield, R.A.: Host Defense System Interactions with Candida. J. Med. Vet. Mycol. 30:89-104 (1992).
77.
Greenspan, J., J.S. Greenspan, J.J. Pindborg, and M. Schiodt: AIDS and the Dental Team. Munksgaard, Copenhagen (1986).
78.
Hay, R.Y.: Fluconazole. J. Infect. 21:1-6 (1990a).
79.
Hay. R. Y.: Overview of Studies of Fluconazole in Oropharyngeal Candidiasis. Revs. Infect. Dis.12(Suppi. 3):334-337 (1990b).
80.
Hazen, R.C. and B.W. Hazen: Temperature-Mediated Physiological Characteristics of Candida albicans. Microbiol. Immunol. 31:497-508 (1987).
81.
Higgs, J.M. and R.S. Wells: Chronic Mucocutaneous Candidosis: Associated Abnormalities of Iron Metabolism. Br. J. Dermatol. 86:88 (1972).
82.
Hill, I.R. and P. Porter: Studies of Bactericidal Activity to Escherichia coli of Procine Serum and Colostral Immunoglobulins and the Role of Lysozyme with Secretory IgA. Immunology26:1239-1250 (1974).
83.
Holmberg, K. and R. Meyer: Fungal Infections in Patients with AIDS and AIDS-Related Complex. Scand. J. Infect. Dis. 18:179-192 (1986).
84.
Holmstrup, P. and T. Axell: Classification and Clinical Manifestations of Oral Yeast Infections. Acta Odontol. Scand. 48:57-59 (1990).
85.
Holmstrup, P. and M. Bessermann: Clinical, Therapeutic and Pathogenic Aspects of Chronic Oral Multifocal Candidiasis. Oral Surg. Oral Med. Oral Pathol. 56:388-395 (1983).
86.
Holmstrup, P. and L.P. Samaranayake: Acute and AIDS Related Oral Candidosis. In: Oral Candidosis, ( L. P. Samaranayake and T. W. MacFarlane, Eds.) Butterworth, London (1990).
87.
Holt, R.J. and A. Azmi: Miconazole Resistant Candida. Lancet1:50-51 (1978).
88.
Humphrey, M.J., S. Jevons, and M.H. Tarib: Pharmacokinetic Evaluation of U.K. 49858, A Metabolically Stable Triazole Antifungal in Animals and Humans. Antimicrobial Agents Chemother. 28:648-653 (1985).
89.
Iacopino, A. and W. Wathen: Oral Candidal Infection and Denture Stomatitis: A Comprehensive Review. J. Am. Dent. Assoc. 123:46-51 (1992).
90.
Jacobs, A. and M. Lord: Iron Containing Enzymes in the Buccal Epithelium. Lancetii:1331 (1961).
91.
Jansen, T., M. van de Ven, M. J. Borgers, F.C. Odds, and J. van Cutsem: Fungal Morphology After Treatment with Itraconazole as a Single Oral Dose in Experimental Vaginal Candidosis in Rats. Am. J. Obstet. Gynecol. 165:1552-1557 (1991 ).
92.
Jeganathan, S. and Y.C. Chan: Immunodiagnosis in Oral Candidiasis. Oral Surg. 74:451-454 (1992).
93.
Jenkins, W.M.M., T.W. MacFarlane, M.M. Ferguson, and D.K. Mason: Nutritional Deficiency in Oral Candidosis. Int. J. Oral Surg. 6:204-210 (1977).
94.
Jepsen, A. and J.E. Winther: Mycotic Infection in Oral Leukoplakia. Acta Odontol. Scand. 23:239-256 (1965).
95.
Johnson, E.M., J. Luker, M. El-Kabir, C. Scully, and D.W. Warnock: Azole-Resistant Candida Species among AIDS Patients Given Long-Term Fluconazole Treatment for Oral Candidosis. Antimicrobial Agents Chemother. (1994) (in press).
96.
Johnson, E.M., M.D. Richardson, and D.W. Warnock: In Vitro Resistance to Imidazole Antifungals in Candida albicans. J. Antimicrobiol. Chemother. 13:547-558 (1984).
97.
Jontell, M., A. Scheynius, S.C. Ohman, and B. Magnusson: Expression of Class II Transplantation Antigens by Epithelial Cells in Oral Candidiasis, Oral Lichen Planus and Gingivitis. J. Oral Pathol. 15:484-488 (1986).
98.
Jorge, A.O.C., M.A.G. Totti, O.P.D. Almeida, and C. Scully: Effect of Sialoadenectomy on the Carriage of Candida albicans in the Mouth of Rats. J. Oral Pathol. Med. 22:138-140 (1993).
99.
Jose, Y., K. Komore, H. Inouye, R. Nomura, M. Mamamura, and K. Tsuji: Role of Macrophages in T Lymphocyte Response to Candida Allergen in Man with Special Reference to HLA-D and DR. Clin. Exp. Immunol. 45:152-157 (1981).
100.
Joynson, D.H.M., D.M. Walker, A. Jacobs, and A.E. Dobby: Defects of Cell Mediated Immunity in Patients with Iron Deficient Anaemia. Lancetii: 1058-1059 (1972 ).
101.
Kamalakshi, B.A., P.R. Santarpia, J.J. Pollack, and R.P. Renner: Assessment of Antimicrobial Treatment of Denture Stomatitis Using an In Vivo Replica Model System: Therapeutic Efficacy of an Oral Rinse. J. Prosthet. Dent. 67:72-77 (1992).
102.
Kennedy, M.J., A.L. Rogers, L.R. Hanselman, D.R. Soll, and R.J. Yance: Variation in Adhesion and Cell Surface Hydrophobicity in Candida albicans White and Opaque Phenotypes. Mycopathologia102:149-156 (1988).
103.
Kennedy, M.J. and P.A. Volz: dissemination of Yeasts After Gastrointestinal Inoculation in Antibiotic-Treated Mice. Sabouraudia21:27-33 (1983).
104.
Kennedy, M.J.: Adhesion and Association Mechanisms of Candida albicans. Curr. Top. Med. Mycol. 2:3-169 (1988).
105.
Kimura, L.H. and N.N. Pearsall: Adherence of Candida albicans to Human Buccal Epithelial Cells. Infect. Immun. 21:64-68 (1978).
Klebanoff, S.J.: Role of the Superoxide Anion in the Myeloperoxidase-Mediated Antimicrobial System. J. Biol. Chem. 249:3724-3728 (1974 ).
108.
Klein. R.S., C.A. Harris, C.B. Small, B. Moll, M. Lesser, and G.H. Friedland: Oral Candidiasis in High-Risk Patients as the Initial Manifestation of Acquired Immunodeficiency Syndrome. N. Eng. J. Med. 311(6):354-358 (1984).
109.
Knight, L. and J. Fletcher: Growth of Candida albicans in Saliva: Stimulation by Glucose Associated with Antibiotics, Corticosteroids and Diabetes Mellitus. J. Infect. Dis. 123:371-377 (1971).
110.
Kostiala, I., A.A.I. Kostiala, and A. Kahanpaa: Oral Mycoses and their Treatment. Acta Odontol. Scand. 37:87-101 (1979).
Kostiala, I., A.A.I. Kostiala, and A. Kahanpaa: Acute Fungal Stomatitis in Patients with Haematologic Malignancies: Quantity and Species of fungi. J. Infect. Dis. 146:101 (1982).
113.
Kremple-Lamprecht, L.: Factors Affecting the Pathogenicity of Candida albicans - A Review, pp. 49-53. In: Candida and Candidamycoses, (E. Tumbay, H. P. V. Seeliger, and O. Ang, Eds.) Plenum Press, New York (1991).
114.
Krogh, P., B. Hald, and P. Holmstrup: Possible Mycological Etiology of Oral Cancer: Catalytic Potential of Infecting Candida albicans and other yeasts in Production of N-Nitrosobenzylmethylamine. Carcinogenesis8:1543-1548 (1987 ).
115.
Krogh, P.: The Role of Yeasts in Oral Cancer by Means of Endogenous Nitrosation. Acta Odontol. Scand. 48:85-88 (1990).
116.
Kurtzman, C.P. and H.J. Phaff: Molecular Taxonomy. In: The Yeasts, Vol. 1, 2nd ed., pp. 63-94. (A. H. Rose and J. S. Harrison, Eds.) Academic Press, London (1987).
117.
Lamey, P.J., A. Drawazeh, B.M. Fisher, L.P. Samaranayake, T.W. MacFarlane, and B.M. Frier: Secretor Status, Candidal Carriage and Candidal Infection in Patients with Diabetes Mellitus. J. Oral Pathol. 17:354-357 (1988).
118.
Lamey, P.J., A.M.G. Drawazeh, J. Muirhead, J.S. Rennie, L.P. Samaranayake, and T.W. MacFarlane: Chronic Hyperplastic Candidosis and Secretor Status. J. Oral Pathol. Med. 20:64-67 (1991).
119.
Lamey, P.J. and L.P. Samaranayake: Oral Candidosis. II. Diagnosis and Management. Dent. Update15:328-331 (1988).
120.
Lehner, T.: Oral Candidosis. Dent. Pract. 17(6):209-216 (1967).
121.
Lehrer, R.I. and M.J. Klein: Leucocyte Myeloperoxidase Deficiency and Disseminated Candidosis: The Role of Myeloperoxidase in Resistance to Candida Infection. J. Clin. Invest. 48:1478-1488 (1969).
122.
Leth, B.A. and A. Stenderup: Deoxyribonucleic Acid Homology in Yeasts. Genetics Relatedness within the Genus Candida. J. Gen. Microbiol. 59:21-30 (1969).
123.
Lewis, M., L.P. Samaranayake, and P. Lamey: Diagnosis and Treatment of Oral Candidosis. J. Oral Maxillofac. Surg. 49:996-1002 (1991).
124.
Lindquist, S. and E. Craig: the Heat-Shock Proteins. Ann. Rev. Gene22:631-677 (1988).
125.
Lodder, J.: The Yeasts: A Taxonomic Study, 2nd ed., North Holland, Amsterdam (1970).
126.
Lombardi, G., A.M. Di Massimo, F. Del Gallo, D. Vismora, E. Piccolella, O. Pugliese, and V. Colizzi: Mechanisms of Action of an Antigen Nonspecific Inhibitory Factor Produced by Human T Cells Stimulated by MPPs and PPD. Cell Imunol. 98:434-443 (1986).
127.
Lombardi, G., D. Vismara, E. Piccolella, V. Colizzi, and G.L. Asherson: A Nonspecific Inhibitor Produced by Candida albicans Activated T Cells Impairs Cell Proliferation by Inhibiting Interleukin-1 Production. Clin. Exp. Immunol. 60:303-310 (1985).
128.
Lucatorto, F., C. Franker, W. Hardy, and S. Chafey: Treatment of Refractory Oral Candidiasis with Fluconazole. Oral Surg. Oral Med. Oral Pathol. 71:42-44 (1991).
129.
MacDonald, F. and F.C. Odds: Virulence for Mice of a Proteinase-Secreting Strain of Candida albicans and a Proteinase-Deficient Mutant. J. Gen. Microbiol. 129:431-438 (1983).
130.
MacDonald, F. and F.C. Odds: Inducible Proteinase of C. albicans in diagnostic Serology and in the Pathogenicity of Systemic Candidosis. J. Med. Microbiol. 13:423-435 (1980).
131.
MacFarlane, T.W.: Ecology and Epidemiology of Candida. In: Oral Candidosis, (L. P. Samaranayake and T. W. MacFarlane, Eds.) Wright, London (1990).
132.
Mason, A.P.P., J.C.P. Weber, and J.M.T. Willoughby: Oral Carriage of Candida albicans, ABO Blood Groups and Secretor Status in Healthy Subjects. J. Med. Vet. Mycol. 26:49-56 (1988).
133.
Masson, P.L. and J.F. Heremans: Lactoferrin in Milk from Different Species. Comp. Biochem. Physiol. 39(B): 119-129 (1971).
134.
Matsumoto, M., S. Matsubana, T. Matsuni, M. Tamura, R. Hattori, H. Nomura, M. Ono, and T. Yokoto: Protective Effect of Human Granulocyte Colony-Stimulating Factor on Microbial Infection in Neutropenic Mice. Infect. Immun. 55:2775 (1987).
135.
Matthews, R., J. Burnie, and S. Tabagchali: Isolation of Immunodominant Antigens from Sera of Patients with Systemic Candidosis and Characterization of Serological Response to C. albicans. J. Clin. Microbiol. 25:230-237 (1987).
136.
Matthews, R.C.: Candida albicans HSP90: Link between Protective and Autoimmunity. J. Med. Microbiol. 26:367-370 (1992).
137.
May, S.J., C.C. Blackwell, and D.M. Weir: Lewis Blood Group Antigen of Nonsecretors: A Receptor for Candida blastospores. FEMS Microbiol. Immunol. 47:407-409 (1989).
138.
McCarthy, G.M., I.D. Mackie, J. Koval, H.S. Sandhu, and T.D. Daley: Factors Associated with Increased Frequency of HIV-Related Oral Candidiasis. J. Oral Pathol. Med. 20:332-336 (1991).
139.
McCourtie, J. and L.J. Douglas: Relationship between Cell Surface Composition, Adherence and Virulence of Candida albicans. Infect. Immun. 45:6-12 (1984).
140.
McGoven, J.J., R.H. Parrott, C.W. Emmous, S. Ross, F.G. Burke, and E.C. Rice: The Effect of Aureomycin and Chloramphenicol on the Fungal and Bacterial Flora of Children. N. Engl. J. Med. 10:297-403 (1953).
141.
Melbye, M., H. Schonheyder, L. Kestens et al.: Carriage of Oral Candida albicans Associated with a High Number of Circulating Suppressor T Lymphocytes. J. Infect. Dis. 152:1356-1357 (1985).
142.
Mestecky, J. and J.R. McGhee: Immunoglobulin A: Molecular and Cellular Interactions Involved in IgA Biosynthesis and Immune Response. Adv. Immunol. 40:153-245 (1987).
143.
Meyer, S.A., D.G. Ahearn, and D.G. Yarrow: The Genus Candida Berkhout. In: The Yeasts: A Taxonomic Study, pp. 584-588. (N. J. W. Kreger-van Rij, Ed.) Elsevier, Amsterdam (1984).
144.
Midtvedt, T.: Ecosystems - Development, Functions and Consequences of Disturbances - with Special Reference to Oral Cavity. J. Clin. Periodontol. 17:474-478 (1990).
145.
Mishra, P., J. Bolard, and R. Prasad: Emerging Role of Lipids of Candida albicans, A Pathogenic Dimorphic Yeast. Biochim. Biophys. Acta1127:1-14 (1992).
146.
Mitchell, K.G., J.A. Bradley, I.M.C.A. Ledingham, and D.N.H. Hamilton: Candida Colonization of the Oral Cavity. Surg. Gynecol. Obstet. 154:870-874 (1982).
147.
Morace, G., C. Archibusacci, M. Sestito, and L. Polonelli: Strain Differentiation of Pathogenic Yeasts by the Killer Systems. Mycopathologia84:81-85 (1983/84).
148.
Newton, A.V.: Denture Sore Mouth: A Possible Aetiology. Br. Dent. J. 112:357-360 (1962).
149.
Nikawa, H., L.P. Samaranayake, and J. Tenouvo: The Fungicidal Effect of Human Lactoferrin on Candida albicans and Candida Krusei. Arch. Oral Biol. 38:1057-1063 (1993 ).
150.
O'Grady, J.F. and P.C. Reade: Candida albicans As a Promoter of Oral Mucosa Neoplasia. Carcinogenesis13:783-786 (1992).
151.
Odds, F.C.: Candida and Candidosis: A Review and Bibliography, 2nd ed., Balliere Tindall, London (1988).
152.
Odman, P.A.: The Effectiveness of An Enzyme-Containing Denture Cleanser. Quint. Int. 23:187-190 (1992).
Okuda, K., K. Ishiwara, Y. Noguchi, T. Takahashi, and I. Tadokoro: New Type of Antibody-Enzyme Conjugate Which Specifically Kills Candida albicans. Infect. Immun. 27:690-692 (1980).
155.
Okuda, T., T. Yasuoka, and N. Okra: Myeloperoxidase Deficiency as a Predisposing Factor for Deep Mucocutaneous Candidiasis. J. Oral Maxillofac. Surg. 49:183-186 (1991).
156.
Oliver, D.E. and W.J. Shillitoe: Effects of Smoking on the Prevalence and Intraoral Distribution of Candida albicans. J. Oral Pathol. 13:265-270 (1984).
157.
Olsen, I.: Chemotaxonomy of Yeasts. Acta Odontol. Scand. 48:19-25 (1990).
158.
Olsen, I.: Denture Stomatitis. Occurrence and Distribution of Fungi. Acta Odontol. Scand. 32:329-333 (1974).
Papadimitriou, J.M. and R.B. Ashman: Macrophages: Current Views on Their Differentiation, Structure and Function. J. Ultrastruct. Pathol. 13:343-372 (1989).
161.
Parvinen, T.: Stimulated Salivary Flow Rate, pH and Lactobacillus and Yeast Concentrations in Persons with Different Types of Dentition. Scand. J. Dent. Res. 92:412-418 (1984).
162.
Pereira, H.A. and C.S. Hosking: The Role of Complement and Antibody in Opsonization and Intracellular Killing of Candida albicans. Clin. Exp. Immunol. 57:307-314 (1984).
163.
Petersen, P.K.: Host Defense Abnormalities Predisposing the Patient to Infection. Am. J. Med. 76:2-10 (1984).
164.
Peterson, D.E., G.E. Minah, and C.D. Overholser: Microbiology of Acute Periodontal Infection in Myelosuppressed Cancer Patients. J. Clin. Oncol. 5:1461-1468 (1987).
165.
Phaff, H.J.: DNA, Enzymes and Cell Wall. In: The Yeasts: A Taxonomic Study, 3rd ed. pp. 17-21. ( N. J. W. Kregervan Rij, Ed.) Elsevier Science Publishers B. V., Amsterdam (1984).
166.
Piccalella, E., G. Lombardi, and R. Morelli: Generation of Suppressor Cells in the Response of Human Lymphocytes to a Polysaccharide from Candida albicans. J. Immunol. 126:2151-2155 (1981).
167.
Pindborg, J.J. and H. Nielsen: Significance of Oral Lesions: Oral Candidiasis. J. Dent. Res. 68:859(Abst.) (1989).
168.
Pindborg, J.J.: Oral Cancer and Precancer. John Wright & Sons, Bristol (1980).
169.
Pindborg, J.J.: Oral Leukoplakia. Austral. Dent. J. 16:83-93 (1971).
170.
Porter, S.R. and C. Scully: Chronic Mucocutaneous Candidosis and Related Syndromes. In: Oral Candidosis, Chap. 11. (L. P. Samaranayake and T. W. MacFarlane, Eds.) Butterworth, London (1990).
171.
Pugh, D. and R. Cawson: The Cytochemical Localization of Phospholipase in Candida albicans Infecting the Chicks Chorio-Allantoic Membrance. Sabouraudia15:29-35 (1977).
172.
Rayhan, R., L. Xu, R.P. Santarpia, C.A. Tylende, and J.J. Pollock: Antifungal Activities of Salivary Histidine-Rich Polypeptides Against Candida albicans and Other Oral Yeast Flora. Oral Microbiol. Immunol. 7:51-52 (1992).
173.
Razek, M.K. and N. Shaaban: Histochemical and Histopathological Studies of Alveolar Mucosa Under Complete Dentures. J. Prosthet. Dent. 39:29-39 (1978).
174.
Rebbe, N., J. Ware, R. Bertina, P. Modrich, and D. Stafford: Nucleotide Sequence of a cDNA for a Member of the Human 90-kDa Heat-Shock Protein Family. Gene53:235-245 (1987).
175.
Redfield, R., D. Wright, and E. Tramont: The Walter Reed Staging Classification for HTLH-III/LAV Infection. N. Engl. J. Med. 314:131-132 (1980).
176.
Rennie, J.S., D.G. MacDonald, and J.H. Dagg: Iron and the Oral Epithelium: A Review. J. Roy. Soc. Med. 77:602 (1984).
177.
Rinaldi, M.G.: Laboratory Evaluation of Antifungal Agents: A Brief Overview. Clin. Infect. Dis. 14:S130-S133 ( 1992).
178.
Roed-Petersen, B., G. Renstrup, and J. Pindborg: Candida in Oral Leukoplakias: A Histologic and Exfoliative Cytologic Study. Scand. J. Dent. Res. 78:323-328 (1970).
179.
Rogers, T.J. and E. Balish: Immunity to Candida albicans. Microbiol. Rev. 44:660-682 (1980).
180.
Rutter, P.R.: Mechanisms of Adhesion. In: Microbial Adhesion and Aggregation. pp. 5-19. (R. C. Marshall, Ed.) Springer-Verlag, Berlin (1984).
181.
Sabin, C.A., A.N. Phillips, J.E. Elford, and C.A. Lee: Progression to AIDS in HIV-Infected Patients with Oral Candidiasis or Hairy Leukoplakia. AIDS6:750-751 (1992).
182.
Saigh, J.H., C.C. Sanders, and W.E. Sanders: Inhibition of Neisseria gonorrhoeae by Aerobic and Facultatively Anaerobic Components of the Endocervical Flora: Evidence for a Protective Effect Against Infection. Infect. Immun. 9:704-710 (1978).
183.
Samaranayake, L.P., D.A.M. Geddes, D.A. Weetman, and T.W. MacFarlane: Growth and Acid Production of Candida albicans in Carbohydrate Supplemented Media. Microbios. 37:105-115 (1983).
184.
Samaranayake, L.P. and P. Holmstrup: Oral Candidiasis and Human Immunodeficiency Virus Infection. J. Oral Pathol. Med. 18:554-564 (1989).
185.
Samaranayake, L.P., A. Hughes, and T.W. MacFarlane: The Proteolytic Potential of Candida albicans in Human Saliva Supplemented with Glucose. J. Med. Microbiol. 17:13-22 (1984a).
186.
Samaranayake, L.P., A. Hughes, D.A. Weetman, and T.W. MacFarlane: Growth and Acid Production of Candida Species in Human Saliva Supplemented with Glucose. J. Oral Pathol. 15:251-254 (1986a).
187.
Samaranayake, L.P. and P.J. Lamey: Oral Candidosis. I. Clinicopathological Aspects. Dent. Update15:227-231 (1988).
188.
Samaranayake, L. P. and T. W. MacFarlane, (Eds.) Oral Candidosis. Butterworth, London (1990).
189.
Samaranayake, L.P., T.W. MacFarlane, P.J. Lamey, and M. Ferguson: A Comparison of Oral Rinse and Imprint Sampling Technique for the Detection of Yeast, Coliform and Staphylococcus aureus Carriage in the Oral Cavity. J. Oral Pathol. 15:386-388 (1986b).
190.
Samaranayake, L.P., T.W. MacFarlane, and M.I. Williamson: Comparison of Sabouraud Dextrose and Pagano-Levin Media for Detection and Isolation of Yeasts from Oral Samples. J. Clin. Microbiol. 25:162-164 (1987).
191.
Samaranayake, L.P. and T.W. MacFarlane: Factors Affecting the In Vitro Adherence of the Fungal Oral Pathogen Candida albicans to Epithelial Cells of Human Origin. Arch. Oral Biol. 27:869-873 (1982).
192.
Samaranayake, L.P. and T.W. MacFarlane: Hypothesis: On the Role of dietary Carbohydrates in the Pathogenesis of Oral Candidosis. FEMS Microbiol. Lett. 27:1-5 (1985).
193.
Samaranayake, L.P., J. McCourtie, and T.W. MacFarlane: Factors Affecting the In Vitro Adherence of Candida albicans to Acrylic Surfaces. Arch. Oral Biol. 25:611-615 (1980).
194.
Samaranayake, L.P., J.M. Raeside, and T.W. MacFarlane: Factors Affecting the Phospholipase Activity of Candida Species In Vitro. Sabouraudia22:201-207 (1984b).
195.
Samaranayake, L.P., A.G. Robertson, T.W. MacFarlane, I. Hunter, G. MacFarlane, and M.M. Ferguson: The Effect of Chlorhexidine Gluconate and Benzydamine Mouthwashes on Mucositis Induced by Therapeutic Irradiation. Clin. Radiol. 39:291-294 (1988).
196.
Samaranayake, L.P. and C. Scully: Oral Candidosis in HIV Infection (Leading Article). Lancetii: 1491-1492 (1989).
197.
Samaranayake, L.P. and H. Yaacob: Classification of Oral Candidosis. In: Oral Candidosis, Chap. 7. (L. P. Samaranayake and T. W. MacFarlane, Eds.) Butterworth, London (1990).
198.
Samaranayake, L.P.: Host Factors and Oral Candidosis. In: Oral Candidosis, Chap. 5, pp. 66-103. (L. P. Samaranayake and T. W. MacFarlane, Eds.) Butterworth, London (1990a).
199.
Samaranayake, L.P.: Nutritional Factors and Oral Candidosis. J. Oral Pathol. 15:61-65 (1986).
200.
Samaranayake, L.P.: Oral Candidosis: An Old Disease in New Guises. Dent. Update17:36-38 (1990b).
Samaranayake, Y.H., T.W. MacFarlane, L.P. Samaranayake, and T. Atchison: The Proteolytic and Saccharolytic Potential of Candida Species Cultured in Human Saliva. Oral Microbiol. Immunol. (1994 ) (In Press).
203.
Sandin, R.L.: The Attachment to Human Buccal Epithelial Cells by Candida albicans: An In Vitro Kinetic Study Using Concavalin A. Mycopathologia98:179-184 (1987).
204.
Scherer, S. and D.A. Stevens: Application of DNA Typing Methods to Epidemiology and Taxonomy of Candida Species. J. Clin. Microbiol. 25:675-679 (1987).
205.
Scully, C. and R. Cawson: Medical Problems in Dentistry, 2nd ed., pp. 447-453 Wright, Bristol (1987).
206.
Scully, C., J. Epstein, and S. Porter: Recognition of Oral Lesions of HIV Infections. I. Candidosis. Br. Dent. J. 169:295-296 (1990).
207.
Scully, C.: Candida and Candidosis. World Workshop on Oral Medicine pp. 191-197. Chicago, Illinois, June, 1988.
Segal, E., I. Kremer, and D. Dayan: Inhibition of Adherence of Candida albicans to Acrylic by a Chitin Derivative. Eur. J. Epidemiol. 8:350-355 (1992).
210.
Selik, R.M., E.T. Strarcher, and J.W. Curran: Opportunistic Diseases Reported in AIDS Patients: Frequencies, Associations, Trends. AIDS1:175-182 (1987).
211.
Shen, H.D., K.B. Choo, W.C. Tasi, T.M. Jen, J.Y. Yeh, and H.S. Han: Differential Identification of Candida Species and Other Yeasts by Analysis of (35s) Methionine-Labeled Polypeptide Profiles. Analyt. Biochem. 175:548-551 (1988).
212.
Shepherd, M.G., R.T.M. Poulter, and P.A. Sullivan: Candida albicans Biology, Genetics and Pathogenicity. Ann. Rev. Microbiol. 39:579-614 (1985).
213.
Shepherd, M.G. and P.A. Sullivan: The Production and Growth Characteristics of Yeasts and Mycelial Forms of Candida albicans in Continuous Culture. J. Gen. Microbiol. 93:361 (1976).
214.
Siegman-Igra, Y. and M.Y. Raban: Failure of Fluconazole in Systemic Candidiasis. Eur. J. Clin. Microbiol. Infect. Dis. 11:201-202 (1992).
215.
Silverman, J., J. Migliorati, L. Epstein, and L.P. Samaranayake: Laboratory Diagnosis of Oral Candidosis. In: Oral Candidosis, ( L. P. Samaranayake and T. W. MacFarlane, Eds.) Butterworth, London (1990).
216.
Slots, J., T.E. Rams, and M.A. Listgarten: Yeasts, Enteric Rods and Pseudomonads in the Subgingival Flora of Severe Adult Periodontitis. Oral Microbiol. Immunol. 3:47-52 (1988).
217.
Smith, D., F. Boag, F. Midgley, and B. Gazzard: Fluconazole Resistant Candida in AIDS. J. Infect. 23:345-346 (1991a).
218.
Smith, D.E., J. Midgley, M. Allan, G.M. Connolly, and B.G. Gazzard: Itraconazole Versus Ketoconazole in the Treatment of Oral and Oesophageal Candidosis in Patients Infected with HIV. AIDS5:1367-1371 (1991b).
219.
Sobel, J.D., P.G. Myers, D. Kay, and M.E. Levison: Adherence of Candida albicans to Human Vaginal and Buccal Epithelial Cells. J. Infect. Dis. 143:76-82 (1981).
Soukka, T., J. Tenovuo, and M. Lenander-Lumikari: Fungicidal Effect of Human Lactoferrin Against Candida albicans. FEMS Microbiol. Lett. 90:223-228 (1992).
Tabak, L., I.D. Mandel, D. Karland, and H. Baurmash: Alterations in Lactoferrin in Salivary Gland Disease. J. Dent. Res. 57:43-47 (1978b).
224.
Takagi, M., K. Moriya, and K. Yano: Induction of Cytochrome P-450 in Petroleum-Assimilating Yeast. I. Selection of a Strain and Basic Characterization of Cytochrome P-450 Induction in the Strain. Cell Mol. Biol. 25:363-369 (1980).
225.
Tamamato, M., T. Hamada, Y. Miyake, and H. Suginaka: Ability of Enzymes to Remove Candida. J. Prosthet. Dent. 53:214-216 (1985).
226.
Tapper-Jones, L., M. Aldred, and D.M. Walker: Prevalence and Intraoral Distribution of Candida albicans in Sjogren's syndrome. J. Clin. Pathol. 33:282-287 (1980).
227.
Tavitian, A., J. Raufman, and L. Rosenthal: Oral Candidiasis as a Marker for Oesophageal Candidiasis in the Acquired Immunodeficiency Syndrome. Ann. Intern. Med. 104:54-55 (1986).
228.
Tenovuo, J., J. Valtakoski, and M.L. Knuuttila: Antibacterial Activity of Lactoperoxidase Adsorbed by Human Salivary Sediment and Hydroxyapatite. Caries Res. 11:257-262 (1977).
229.
Tobgi, R.S., L.P. Samaranayake, and T.W. MacFarlane: In Vitro Susceptibility of Candida Species to Lysozyme. Oral Microbiol. Immunol. 3:35-39 (1988).
230.
Tronchin, G., J.P. Bauchara, R. Robert, and J.M. Senet: Adherence of Candida albicans Germ Tubes to Plastic: Ultrastructural and Molecular Studies of Fibrillar Adhesion. Infect. Immun. 56:1987-1993 (1988).
231.
Tronchin, G., D. Poulain, and A. Vernes: Cytochemical and Ultrastructural Studies of Candida albicans. III. Evidence for Modifications of the Cell Wall Coat during Adherence to Human Buccal Epithelial Cells. Arch. Microbiol. 139:221-224 (1984).
232.
Tumbay, E., H.P.V. Seeliger, and O. Ang: Candida and Candidamycosis, Plenum Press, New York (1991).
233.
Valder, J.C., O.E. Mason, A. Sirena, and N.G. de Alderete: Characteristics of DTH Suppressor Cells in Mice Infected with Candida albicans. Mycopathologia98:121-126 (1987).
234.
van den Bossche, H.: Anti-Candida Drugs - Mechanisms of Action. In: Candida and Candidamycosis, pp. 83-95. (E. Tumbay, H. P. V. Seeliger, and O. Ang, Eds.) Plenum Press, New York (1991).
235.
Vudhichamnong, K., D.M. Walker, and H.C. Ryley: The Effect of Secretory Immunoglobulin A on the In Vitro Adherence of the Yeast Candida albicans to Human Oral Epithelial Cells. Arch. Oral Biol. 27:617-621 (1982).
236.
Walker, D.M. and T.M. Arendorf: Candidal Leukoplakia, Chronic Multifocal Candidosis and Median Rhomboid Glossitis. In: Oral Candidosis, Chap. 10. ( L. P. Samaranayake and T. W. MacFarlane, Eds.) Butterworth, London (1990).
237.
Warnakulasuriya, K.A.A.S., L.P. Samaranayake, and J.S.M. Peiris: Angular Cheilitis in a Group of Sri Lankan Adults. J. Oral Pathol. Med. 20:172-175 (1991).
238.
Warnock, D.W.: Amphotericin B: An Introduction. J. Antimicrobiol. Chemother. 28(Suppl. B):27-38 (1991).
239.
Washton, H.: Review of Fluconazole: A New Triazole Antifungal Agent. Diagn. Microbiol. Infect. Dis.12:229s-233s ( 1989).
240.
Watson, I. and D. MacDonald: Oral Mucosa and Complete Dentures. J. Prosthet. Dent. 47:133-140 (1982).
241.
Weijman, A.C.M. and L. Rodriguez De Miranda: Carbohydrate Patterns of Candida, Cryptococcus and Rhodtorula species. Antonie van Leeuwenhoek54:535-543 (1988).
242.
Weinberg, E.D.: Iron and Susceptibility to Infectious Disease. Science184:952-956 (1974).
243.
Wells, C. and A.M. Lever: Dose-Dependent Fluconazole Hepatoxicity Proven on Biopsy and Rechallenge. J. Infect. 24:111-112 (1992).
244.
Wilkieson, C., L.P. Samaranayake, T.W. MacFarlane, and P.J. Lamey: Oral Candidosis in the Elderly in Long-Term Hospital Care. J. Oral PathoL Med. 20:13-16 (1991).
245.
Wilton, J.M. and T. Lehner: Immunology of Candidiasis. Comp. Immunol. 8:525-559 (1980).
246.
Wilton, J.M. and T. Lehner: Immunology of Candidiasis. In: Immunology of Human Infection, p. 525. (E. J. Nahmias, andR. J. O'Reilly, Eds.) Plenum Medical, New York (1981).
247.
Young, T.W.: Killer Yeasts. In: The Yeasts, Vol. 2, 2nd ed. pp. 131-164. (A. H. Rose and H. S. Harrison, Eds.) Academic Press, London (1987).
